Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02568722 · ClinicalTrials.gov registry record · NA
Standard vs. Accelerated Initiation of RRT in Acute Kidney Injury (STARRT-AKI: Principal Trial)
A NA study, sponsored by Unity Health Toronto.
- Completed
- Registry status
- NA
- Development phase
- 3,019
- Enrollment target
NCT02568722: Completed NA study, sponsored by Unity Health Toronto.
NCT02568722 is a NA study that has completed, run by Unity Health Toronto. The registered enrollment target is 3,019 participants, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (115% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02568722, a NA study, has completed, sponsored by Unity Health Toronto.
- COMPLETED
- Registry status
- NA
- Development phase
- 3,019 participants
- Enrollment target
Study Summary
The objectives of this trial are to determine whether, in critically ill patients with severe acute kidney injury (AKI), randomization to accelerated initiation of renal replacement therapy (RRT), compared to standard initiation, leads to: 1. Improved survival (primary outcome); and 2. Recovery of kidney function (principal secondary outcome), defined as independence from RRT at 90 days
Interventions
- OTHER Standard RRT initiation
- OTHER Accelerated RRT initiation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3,019 participants |
| Start Date | 2015-10 |
| Est. Completion | 2019-12 |
| Phase | NA |
What the finished NCT02568722 record still lists
NCT02568722 is an interventional study that assigns participants to a tested intervention. Its 3,019 participants enrollment target places it among the larger protocols in the corpus, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (115% higher).
The record links to 0 conditions, and to 2 interventions - of which Standard RRT initiation is the first listed.
NCT02568722 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02568722 about?
NCT02568722 is a clinical study titled "Standard vs. Accelerated Initiation of RRT in Acute Kidney Injury (STARRT-AKI: Principal Trial)". The objectives of this trial are to determine whether, in critically ill patients with severe acute kidney injury (AKI), randomization to accelerated initiation of renal replacement therapy (RRT), compared to standard initiation, leads to: 1. Improved survival (primary outcome); and 2. Recovery of ...
What is the current status of trial NCT02568722?
This trial is currently completed. It is a NA study. The enrollment target is 3,019 participants. The study started on 2015-10. Estimated completion is 2019-12.
What interventions are being tested in trial NCT02568722?
The interventions under investigation include: Standard RRT initiation (OTHER), Accelerated RRT initiation (OTHER).
Who is sponsoring clinical trial NCT02568722?
This trial is sponsored by Unity Health Toronto, which has 12 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02568722's enrollment target sits among peer trials
3,019 40th of 2000 higher than 1,961 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00004847 · 3,000 participants · Phase 1
Diagnosis of Pheochromocytoma
- NCT00478712 · 3,000 participants
Hirschsprung Disease Genetic Study
- NCT00579566 · 3,000 participants
Novel Biochemical and Molecular Determinants for Soft Tissue Sarcoma
- NCT00816114 · 3,000 participants
Chart Review Study of Chronic Myelogenous Leukemia (CML) Patients Treated With Imatinib Outside of a Clinical Trial
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia